If you are active innovators looking for the business development of Drug Discovery and Development in China, IDDST 2008 provides you perfect face2face opportunities through such overload innovators' presentations and so much breakthrough showcases for your choose. You can not only meet those big pharma decision makers or the investors looking for the investment opportunities. Bring your updated pipeline progress or even your concept proof the technologies in front of your potential customers and investors. If you have exciting discovery optioned for technology transfers, joint venture, or you have competitive service capacities in the following areas, you should take them with you to join IDDST!

1) What Bio or Pharma Business Models suitable for setting up across cultural biotech company in China ?

2) How to Attract Early Stage Capital ?

3) How to Attract US Capital for China ?

4) How are IPOs valued in China and who are buyers of biotechnology?

5) The Successful Case Studies from Recent winners

6) How to define Your Value-added bio-Outsourcing?

7) Current Trends in Seed & Early Stage Investing in Biotechnology

8) How to draw your roadmap to run your business and a necessity for raising capital?
9) Can you define your valuations to avoid a sensitive subject to VCs?

10) You already owned Lead or Drug Candidate Identified

11) You have Drug Target Validation Technologies

12) You own Screening Platform

13) You own Novel compound libraries

14) Drug Candidate entering Phase I, II and III

15) You have Bio-molecule Production GLP or GMP Facilities

16) You have Genomics & Proteomics R & D Capacities

17) You have RNAi, siRNA, mRNA R & D Capacities

18) You have Systems Biology and/or Electronic Biology Capacities

19) You have Biochip R & D Technologies or Products

20) You have Bioelectronics for Drug Discovery

21) You have Bioinformatics R & D Team

22) You have CRO and CMO Capacities

23) You have Medichem GLP Capacities

24) You can provide GLP Molecular Biology Services

25) You can provide Bioanalysis

26) You have PK & PD Service Capacities

27) You have High Throughput Analytical Capacities (NMR, MS, LC-MS, or Maldi-TOF)

28) You have Stem Cell Therapeutics or R & D Capacities

29) You can provide GCP Clinical Research & Trials,

30) Having Anti-cancer Molecule

31) Having Anti-Viral Molecule

32) Having Anti-Inflammatory Molecule

33) Having Anti-Autoimmune Molecule

34) Having Antidiabetes Molecule

35) Having Anti-CNS Disorder Molecule

37) Having Potential New vaccines,

38) Having New Monoclonal Antibodies

39) Can do Translational Medical Sciences

40) Have GLP/GMP Protein Engineering Capacity

41) Have GLP Animal Resources

42) Have FDA Acceptable Clinical Trial Support

43) Have R & D Outsourcing Capacities

44) Have Inspected GMP/GCP Facilities

45) and other unique technologies or products to support drug discovery

If you are interested in bring your innovation to our coleagues and your potential partners, customers or your investors,

Join us Now!

Emily Liu
Project Leader
The Organizing Committee of IDDST 2008
BIT Life Sciences
26 Gaoneng St . , F4
Dalian Hightech Zone
Dalian , LN 116025, China
Tel: 0086-411-84799609x810
Fax: 0086-0411-84799629
Email: emily@iddst.com

Kelly Wang
CEO of BIT Life Sciences, Inc.
26 Gaoneng St . , F4
Dalian Hightech Zone
Dalian , LN 116025, China
Tel: 0086-411-84799609x811
Fax: 0086-0411-84799629
Email: kelly@iddst.com